Clark & Elbing LLP
Methods of treating cancer using PD-1 axis binding antagonists and tigit inhibitors
The present invention describes combination treatment comprising a PD-1 axis binding antagonist and an agent that decreases or inhibits TIGIT expression and/or activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
Genentech, Inc.
A C Y A A A A A A A C C C C A A C C C A A A C C C C A C
A61P C07K Y02A A61P A61P A61K A01K A01K A61K A01K C07K C07K C07K C07K A01K A61K C07K C07K C07K A61K A61P A01K C07K C07K C07K C07K A61P C07K
inventional additional additional inventional inventional inventional additional additional inventional inventional inventional inventional inventional inventional additional additional inventional inventional inventional inventional inventional additional inventional inventional inventional inventional inventional inventional
Jane Jason Dan Kristin Bryan Laetitia Robert J. Xin
Grogan Hackney Eaton Bowles Irving Comps-Agrar Johnston Yu